Ascending Dose Study of the Safety and Tolerability of REGN668(SAR231893) in Normal Healthy Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Regeneron Pharmaceuticals
Related studies linked through entity extraction aliases.
Vascular Endothelial Growth Factor (VEGF) Trap-Eye: Investigation of Efficacy and Safety in Central Retinal Vein Occlusion (CRVO)
- Status
- COMPLETED
- Phase
- PHASE3
A Multiple-dose Study of the Safety and Tolerability of REGN88(SAR153191) in Rheumatoid Arthritis Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Single Injection of REGN475/SAR164877 in the Treatment of Chronic Pancreatitis Pain
- Status
- TERMINATED
- Phase
- PHASE2
Single Injection of REGN475/SAR164877 in Treatment of Vertebral Fracture Pain
- Status
- TERMINATED
- Phase
- PHASE2
A Study to Evaluate the Safety and Efficacy of Subcutaneously Administered REGN475(SAR164877) in Patients With Sciatic Pain
- Status
- COMPLETED
- Phase
- PHASE2
Open-label Extension Study of Intravitreal Aflibercept Injection (IAI; EYLEA®; BAY86-5321) in Neovascular ("Wet") Age-related Macular Degeneration (AMD)
- Status
- COMPLETED
- Phase
- PHASE3
PREventative Study Against URate-Lowering Drug-Induced Gout Exacerbations (PRE-SURGE 2)
- Status
- COMPLETED
- Phase
- PHASE3
A Study of the Safety and Efficacy of REGN475(SAR164877) in Patients With Osteoarthritis of the Knee
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Vascular Endothelial Growth Factor (VEGF) Trap-Eye: Investigation of Efficacy and Safety in Central Retinal Vein Occlusion (CRVO)
- Status
- COMPLETED
- Phase
- PHASE3
Study of Intravenous Aflibercept in Combination With FOLFIRI in Japanese Patients With Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Evaluate the Effects of Aflibercept on QTc Interval in Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE1
A Multiple-Ascending-Dose Study of the Safety and Tolerability of REGN421(SAR153192) in Patients With Advanced Solid Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
A Single-Dose Study of the Safety and Tolerability of REGN475(SAR164877) in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Review of Safety Using Rilonacept in Preventing Gout Exacerbations (RE-SURGE)
- Status
- COMPLETED
- Phase
- PHASE3
Study Utilizing Rilonacept in Gout Exacerbations
- Status
- COMPLETED
- Phase
- PHASE3
PREventative Study Against URate-lowering Drug-induced Gout Exacerbations 1
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Aflibercept Administered in Combination With Pemetrexed and Cisplatin in Participants With Advanced Carcinoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
DME And VEGF Trap-Eye [Intravitreal Aflibercept Injection (IAI;EYLEA®;BAY86-5321)] INvestigation of Clinical Impact
- Status
- COMPLETED
- Phase
- PHASE2
The Longevity Genes in Founder Populations Project
- Status
- RECRUITING
- Phase
- N/A